Analysts Issue Forecasts for HealthEquity FY2028 Earnings

HealthEquity, Inc. (NASDAQ:HQY - Free Report) - Stock analysts at Zacks Research dropped their FY2028 earnings per share estimates for shares of HealthEquity in a research report issued on Tuesday, April 15th. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of $4.62 for the year, down from their prior forecast of $4.65. The consensus estimate for HealthEquity's current full-year earnings is $2.32 per share.

A number of other research analysts have also recently commented on HQY. Wells Fargo & Company upped their price target on HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a research note on Wednesday, February 26th. KeyCorp reduced their price target on shares of HealthEquity from $110.00 to $100.00 and set an "overweight" rating on the stock in a research report on Wednesday. Barrington Research restated an "outperform" rating and issued a $112.00 price objective on shares of HealthEquity in a report on Friday, April 11th. The Goldman Sachs Group reduced their target price on shares of HealthEquity from $107.00 to $94.00 and set a "neutral" rating on the stock in a report on Thursday, March 27th. Finally, Raymond James upgraded shares of HealthEquity from an "outperform" rating to a "strong-buy" rating and dropped their price target for the stock from $120.00 to $115.00 in a research note on Tuesday, March 25th. One investment analyst has rated the stock with a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Buy" and a consensus price target of $111.75.

HealthEquity Trading Up 2.5 %

HQY stock traded up $2.03 during trading on Wednesday, reaching $84.52. 944,006 shares of the stock were exchanged, compared to its average volume of 765,335. The firm has a market capitalization of $7.31 billion, a price-to-earnings ratio of 77.54, a P/E/G ratio of 1.60 and a beta of 0.49. The company has a current ratio of 3.20, a quick ratio of 3.20 and a debt-to-equity ratio of 0.51. The business has a 50 day moving average price of $94.78 and a 200-day moving average price of $96.30. HealthEquity has a 1 year low of $65.01 and a 1 year high of $115.59.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the business. Pier Capital LLC acquired a new stake in shares of HealthEquity during the fourth quarter worth about $8,024,000. HighTower Advisors LLC lifted its position in HealthEquity by 4.8% during the 4th quarter. HighTower Advisors LLC now owns 95,075 shares of the company's stock worth $9,122,000 after acquiring an additional 4,370 shares during the period. Geneva Capital Management LLC lifted its position in HealthEquity by 24.6% during the 4th quarter. Geneva Capital Management LLC now owns 1,048,903 shares of the company's stock worth $100,642,000 after acquiring an additional 206,894 shares during the period. Charles Schwab Investment Management Inc. grew its stake in shares of HealthEquity by 2.4% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,086,811 shares of the company's stock valued at $104,280,000 after purchasing an additional 25,004 shares during the last quarter. Finally, Venturi Wealth Management LLC acquired a new position in shares of HealthEquity in the fourth quarter valued at approximately $238,000. 99.55% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at HealthEquity

In related news, Director Robert W. Selander sold 5,750 shares of the firm's stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the transaction, the director now owns 78,219 shares in the company, valued at $8,704,992.51. This trade represents a 6.85 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Michael Henry Fiore sold 8,881 shares of the business's stock in a transaction that occurred on Friday, April 4th. The shares were sold at an average price of $78.26, for a total value of $695,027.06. Following the completion of the sale, the executive vice president now owns 56,655 shares of the company's stock, valued at approximately $4,433,820.30. This represents a 13.55 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 20,381 shares of company stock valued at $1,781,432. Corporate insiders own 2.20% of the company's stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.